Tag Archives: Prostate Cancer

PCa Patients on HD Would Benefit from Early Kidney Transplantation – Renal and Urology News

Posted on May 13, 2012 by Dr. Savatta

However, study findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest that patients with prostate cancer (PCa) might be better served by undergoing transplantation instead of waiting two years to be declared cancer-free. via PCa Patients on … Continue reading →

Posted in Prostate Cancer | Tagged , , | Leave a comment

Prostate-Cancer Mortality at 11 Years of Follow-up — NEJM

Posted on March 18, 2012 by Dr. Savatta

After a median follow-up of 11 years in the core age group, the relative reduction in the risk of death from prostate cancer in the screening group was 21% rate ratio, 0.79; 95% confidence interval [CI], 0.68 to 0.91; P=0.001, … Continue reading →

Posted in For patients, Prostate Cancer | Tagged , , | Leave a comment

5-ARI delays prostate cancer progression in men with low-risk disease – ModernMedicine

Posted on February 9, 2012 by Dr. Savatta

The 5-alpha-reductase inhibitor dutasteride Avodart appears to delay disease progression and the initiation of active treatment in men with low-risk, localized prostate cancer, results of a 3-year international clinical trial indicate.Treatment with dutasteride also reduces cancer-related anxiety, study authors found.”The … Continue reading →

Posted in Prostate Cancer | Tagged , , , | Leave a comment

Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes – Renal and Urology News

Posted on August 7, 2011 by Dr. Savatta

Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes via Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes – Renal and Urology News. Statins are medicines that are taken to lower cholesterol.  Many studies have shown they are beneficial … Continue reading →

Posted in Prostate Cancer | Tagged , , | Leave a comment

Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer — NEJM

Posted on July 17, 2011 by Dr. Savatta

Among patients with stage T1b, T1c, T2a, or T2b prostate adenocarcinoma and a PSA level of 20 ng per milliliter or less, the use of short-term ADT for 4 months before and during radiotherapy was associated with significantly decreased disease-specific … Continue reading →

Posted in Prostate Cancer | Tagged , , | Leave a comment

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

Posted on June 8, 2011 by Dr. Savatta

INTERPRETATION: 6 months of neoadjuvant androgen deprivation combined radiotherapy is an effective treatment option for locally advanced prostate cancer, particularly in men without nodal metastases or pre-existing metabolic comorbidities that could be exacerbated by prolonged androgen deprivation. via Short-term neoadjuvant … Continue reading →

Posted in Prostate Cancer | Tagged , , | Leave a comment